Skip to main content
. 2022 Oct 20;23(20):12643. doi: 10.3390/ijms232012643

Figure 7.

Figure 7

Hepatoprotective effects of esculetin: Esculetin downregulates the expression of SREBP1c, fatty acid synthetase, and TGF-β-mediated hepatic fibrosis. Esculetin also activates AMPK signaling pathway and inhibits the action of PPARγ, Fasn, Pap, and Dgat2, thus inhibiting the pathogenesis of the fatty liver disease. : Overexpression; : inhibition.